ly2109761 ly Search Results


tgf β receptor i ii inhibitor ly2109761  (R&D Systems)
90
R&D Systems tgf β receptor i ii inhibitor ly2109761
(A) Representative images of crystal violet-stained transwell membranes from JEG-3 cells treated for 24 hours with either TGFB1 or the TGF-β receptorI/II inhibitor <t>LY2109761</t> followed by a 48-hour treatment with 0.028 or 10uM Cd. (B) Quantitative results of the transwell analysis. Cells treated with TGFB1 and Cd was compared to cells treated with TGFB1 only (control) to determine significance, while cell treated with LY2109761 and Cd were compared to cells treated with LY2109761 only (control). *=p<0.05; **=p<0.01; ***=p<.001
Tgf β Receptor I Ii Inhibitor Ly2109761, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgf β receptor i ii inhibitor ly2109761/product/R&D Systems
Average 90 stars, based on 1 article reviews
tgf β receptor i ii inhibitor ly2109761 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
tgf b inhibitors ly 2109761  (Tocris)
86
Tocris tgf b inhibitors ly 2109761
(A) Representative images of crystal violet-stained transwell membranes from JEG-3 cells treated for 24 hours with either TGFB1 or the TGF-β receptorI/II inhibitor <t>LY2109761</t> followed by a 48-hour treatment with 0.028 or 10uM Cd. (B) Quantitative results of the transwell analysis. Cells treated with TGFB1 and Cd was compared to cells treated with TGFB1 only (control) to determine significance, while cell treated with LY2109761 and Cd were compared to cells treated with LY2109761 only (control). *=p<0.05; **=p<0.01; ***=p<.001
Tgf B Inhibitors Ly 2109761, supplied by Tocris, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgf b inhibitors ly 2109761/product/Tocris
Average 86 stars, based on 1 article reviews
tgf b inhibitors ly 2109761 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier
ly364947 or trki  (Eli Lilly)
90
Eli Lilly ly364947 or trki
(A) Representative images of crystal violet-stained transwell membranes from JEG-3 cells treated for 24 hours with either TGFB1 or the TGF-β receptorI/II inhibitor <t>LY2109761</t> followed by a 48-hour treatment with 0.028 or 10uM Cd. (B) Quantitative results of the transwell analysis. Cells treated with TGFB1 and Cd was compared to cells treated with TGFB1 only (control) to determine significance, while cell treated with LY2109761 and Cd were compared to cells treated with LY2109761 only (control). *=p<0.05; **=p<0.01; ***=p<.001
Ly364947 Or Trki, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ly364947 or trki/product/Eli Lilly
Average 90 stars, based on 1 article reviews
ly364947 or trki - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


(A) Representative images of crystal violet-stained transwell membranes from JEG-3 cells treated for 24 hours with either TGFB1 or the TGF-β receptorI/II inhibitor LY2109761 followed by a 48-hour treatment with 0.028 or 10uM Cd. (B) Quantitative results of the transwell analysis. Cells treated with TGFB1 and Cd was compared to cells treated with TGFB1 only (control) to determine significance, while cell treated with LY2109761 and Cd were compared to cells treated with LY2109761 only (control). *=p<0.05; **=p<0.01; ***=p<.001

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Article Title: Cadmium inhibits placental trophoblast cell migration via miRNA regulation of the transforming growth factor beta (TGF-β) pathway

doi: 10.1016/j.fct.2017.07.059

Figure Lengend Snippet: (A) Representative images of crystal violet-stained transwell membranes from JEG-3 cells treated for 24 hours with either TGFB1 or the TGF-β receptorI/II inhibitor LY2109761 followed by a 48-hour treatment with 0.028 or 10uM Cd. (B) Quantitative results of the transwell analysis. Cells treated with TGFB1 and Cd was compared to cells treated with TGFB1 only (control) to determine significance, while cell treated with LY2109761 and Cd were compared to cells treated with LY2109761 only (control). *=p<0.05; **=p<0.01; ***=p<.001

Article Snippet: TGFB1 (R&D Systems, Minneapolis, MN) and TGF-β receptor I/II Inhibitor LY2109761 (Selleckchem, Houston, TX) was added to cultured media for a final concentration of 10ng/mL and 5uM for 24 hours prior to Cd treatment, respectively.

Techniques: Staining, Control